18 May 2016
LIBERUM: Genus - Strategic alliance in gene editing CRISPR-cas9 technology
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
LIBERUM: Genus - Strategic alliance in gene editing CRISPR-cas9 technology
Genus plc (GNS:LON) | 1,717 206 0.7% | Mkt Cap: 1,134m
- Published:
18 May 2016 -
Author:
Sophie Jourdier | Lisa De Neve -
Pages:
3